Autoimmune Lupus Enteritis with Pan Gastrointestinal Involvement in an Adult Patient with Systemic Lupus Erythematosus: Complete Response to Belimumab

نویسندگان

چکیده

Autoimmune lupus enteritis in systemic erythematosus (SLE) is a rare manifestation that comprises of gastrointestinal tract inflammation with supportive images and/or biopsy findings. We report unique case widespread occurring late the disease process and isolation without additional features active SLE but presence serological activity. There was no clear evidence mesenteric vasculitis, intestinal pseudo-obstruction, protein-losing enteropathy, or coagulopathy by imaging histopathology. This first reported an patient pan-gastrointestinal involvement responding to Belimumab, complete resolution syndrome further recurrence events. Rapid diagnosis prompt immunomodulatory treatment lupus-related are critical avoid potentially life-threatening complications.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Refractory Angioedema in a Patient with Systemic Lupus Erythematosus

Angioedema secondary to C1 inhibitor deficiency has been rarely reported to be associated with systemic lupus erythematosus. A genetic defect of C1 inhibitor produces hereditary angioedema, which is usually presented with cutaneous painless edema, but edema of the genital area, gastrointestinal and laryngeal tracts have also been reported.In lupus patients, angioedema may be the result of an ac...

متن کامل

Belimumab in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is one of the most challenging autoimmune disorders with a complex pathophysiology and diverse clinical presentation. Many drugs have been used to treat SLE with suboptimal results, especially in patients with moderate-to-severe disease. Belimumab is the first biological drug to be approved for the treatment of SLE in more than 50 years. This monoclonal antibo...

متن کامل

Belimumab in Systemic Lupus Erythematosus

Belimumab is the only approved biological agent for the treatment of systemic lupus erythematosus (SLE). It is a fully humanized IgG1γ monoclonal antibody directed against soluble B lymphocyte stimulator (BLyS). It is indicated as an add-on therapy for the treatment of adult patients with active, autoantibody-positive SLE, who are receiving standard therapy. Belimumab is generally well-tolerate...

متن کامل

Relapsing lupus enteritis in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease and has systemic features that can affect all organs. Steroid therapy is an essential treatment option in SLE involving the kidneys, other internal organs, or central nervous system. A 42-year-old woman with a 10-year history of SLE presented with nonspecific nausea, vomiting, and diarrhea. She experienced lupus enteritis 7 yea...

متن کامل

Neurobrucellosis in systemic lupus erythematosus

Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Community Hospital Internal Medicine Perspectives

سال: 2023

ISSN: ['2000-9666']

DOI: https://doi.org/10.55729/2000-9666.1185